课题基金 / 基金详情

Aquaporin 1 and pulmonary hypertension

Aquaporin 1 and pulmonary hypertension
水通道蛋白 1 和肺动脉高压
批准号:
9187956
负责人:
Larissa A. Shimoda
金额:
$40.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-12-01 至 2018-11-30

项目摘要

项目成果

Larissa A. Shimoda的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Pulmonary hypertension is a severely debilitating disease with no cure. Morphometric studies revealed that the development of pulmonary hypertension is associated with structural remodeling of the small pulmonary arteries, characterized by thickening of the smooth muscle cell layer and extension of new muscle around previously non-muscular precapillary arterioles. While the former is thought to be due to pulmonary arterial smooth muscle cell (PASMC) hypertrophy, hyperplasia and resistance to apoptosis, the latter is believed to result from PASMC migration. Our laboratory identified a new candidate as a regulator of PASMC migration, proliferation and survival: aquaporins (AQPs). AQPs are a family of proteins that form transmembrane channels which facilitate the transport of water into and out of cells. We have evidence that aquaporin 1 (AQP1), the first family member identified, is expressed in PASMCs, induced by hypoxia and required for PASMC migration and proliferation. Moreover, we have generated exciting data indicating a critical role for the AQP1 C-terminal tail, but not water transport, in controlling these cellular processes. Our preliminary data also indicate that increased AQP1 protein is associated with elevated �atenin expression, a protein that regulates migratory, proliferative and survival responses in PASMCs. How AQP1 regulates �atenin levels is unknown, but we show that the AQP1 cytoplasmic tail is required. Finally, while we have strong evidence that AQP1 plays a critical role in mediating PASMC migration and proliferation, whether AQP1 contributes to the development of vascular remodeling and PH remains unknown. Thus, the goals of this study are to: 1) elucidate the mechanism by which hypoxia upregulates AQP1 in PASMCs; 2) identify the mechanism by which AQP1 modulates �atenin expression and determine whether �atenin is required for AQP1-mediated changes in cell function; and 3) determine whether AQP1 plays a role in facilitating pulmonary hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aquaporin 1 and pulmonary hypertension
  • 批准号:
    10538750
  • 项目类别:
  • 资助金额:
    $70.46万
  • 财政年份:
    2014
  • 负责人:
    Larissa A. Shimoda
  • 依托单位:
Functional linkage of NHE1 and calpain in IPAH
  • 批准号:
    8354085
  • 项目类别:
  • 资助金额:
    $8.1万
  • 财政年份:
    2012
  • 负责人:
    Larissa A. Shimoda
  • 依托单位:
Functional linkage of NHE1 and calpain in IPAH
  • 批准号:
    8526547
  • 项目类别:
  • 资助金额:
    $7.71万
  • 财政年份:
    2012
  • 负责人:
    Larissa A. Shimoda
  • 依托单位:
Interrogation of the Cellular Pathogenesis of Pulmonary Hypertension
  • 批准号:
    8197835
  • 项目类别:
  • 资助金额:
    $24.6万
  • 财政年份:
    2011
  • 负责人:
    Larissa A. Shimoda
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: